Exencial Wealth Advisors LLC Sells 7,998 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Exencial Wealth Advisors LLC has sold 7,998 shares of GE HealthCare Technologies, reducing its position by 4.3% and now holds 176,329 shares worth approximately $13.06 million.
• Several analysts have downgraded GE HealthCare Technologies' stock, with Citigroup lowering its price target from $93 to $83, while Barclays initiated coverage with an equal weight rating and an $86 target.
• GE HealthCare Technologies will pay a quarterly dividend of $0.035 on November 14th, 2023, reflecting a 0.2% dividend yield.

Exencial Wealth Advisors LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 4.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 176,329 shares of the company's stock after selling 7,998 shares during the period. Exencial Wealth Advisors LLC's holdings in GE HealthCare Technologies were worth $13,061,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of GEHC. N.E.W. Advisory Services LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at about $25,000. Bogart Wealth LLC lifted its stake in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after purchasing an additional 247 shares during the last quarter. Stonebridge Financial Group LLC lifted its stake in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $34,000. Finally, Olde Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the first quarter worth approximately $35,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research reports. Citigroup downgraded shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an "equal weight" rating and a $86.00 price target for the company. BTIG Research lifted their price target on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a "buy" rating in a research report on Monday, October 13th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, September 20th. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and an average target price of $85.20.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $76.10 on Wednesday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The stock has a market cap of $34.74 billion, a price-to-earnings ratio of 15.59, a P/E/G ratio of 2.88 and a beta of 1.13. The company's fifty day moving average is $74.60 and its 200 day moving average is $72.16.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter in the previous year, the firm posted $1.00 earnings per share. GE HealthCare Technologies's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.